Company at a Glance


PEL’s Financial Services segment offers a comprehensive suite of financial products to meet the diverse and evolving needs of its customers. The Company has created its unique positioning in the financial services space through its strong presence in the following sub-segments:

Wholesale Lending

Alternative Asset Management

Housing Finance

  • Loan book of ` 24,975 Crores - lending to real estate developers and under Corporate Finance Group (CFG) providing financing solutions to various businesses across varied sectors

  • Consistently expanding product portfolio across both Real Estate developer financing and Corporate Financing platforms
  • ` 7,157 Crores of alternative assets under management

  • Strategic alliances with large reputed partners like APG, CPPIB, Bain Capital Credit and Ivanhoé Cambridge (a real estate subsidiary of CDPQ)
  • Applied to National Housing Bank for incorporating a Housing Finance Company (HFC)

  • Will leverage PEL's strong relationship with Real Estate developers to diversify its lending into retail finance

Investment in Shriram Group

20% stake in Shriram Capital (SCL)

~10% stake in Shriram City Union Finance (SCUF)

~10% stake in Shriram Transport Finance (STFC)

Mr. Ajay Piramal is the Chairman of Shriram Capital


In Pharma, PEL enjoys a strong presence in Global Pharma and India Consumer Products businesses.

Global Pharma

India Consumer Products

  • Strong portfolio of differentiated branded generic products, API generics and vitamins

  • Provides end-to-end contract development and manufacturing capabilities across APIs and formulations

  • Large distribution network in 110+ countries
  • 13 manufacturing facilities in North America, Europe and Asia - all key sites are periodically approved by USFDA

  • Strong presence in the US, Europe, India and Japan

  • Only global company with all four generations of inhalation anaesthesia products
  • Strong brand portfolio with 6 brands among the top 100 brands of India

  • Wide distribution network reaching 420,000 outlets across 2,000 towns with 20,000+ population

  • Asset-light model with third-party manufacturing

  • JV with Allergan - India leader in ophthalmology


PEL’s Healthcare Insight and Analytics business, Decision Resources Group (DRG), is a best-in-class, decision support platform in the healthcare information services space.

It provides indispensable insights to life sciences companies, and healthcare providers and payers, through a variety of high value-added data and analytics, research reports and knowledge-based services. These offerings enable customers to make informed investment, cost containment, commercial optimisation and strategic business decisions in their chosen markets.

  • Product categories - Data and Analytics, Research Products and Global Consulting Services

  • Headquartered in the US, with presence in Canada, Europe, Hong Kong, Japan, China and India

  • Clients include most of the top 50 pharma companies
  • Strengthening presence in payers and providers market

  • Strong revenue visibility

  • Over 70% of revenue is recurring in nature

  • ~96% revenue retention by value across entire customer base